Predictive Factors for Complete Response to Desmopressin Treatment in Children With Primary Monosymptomatic Nocturnal Enuresis.

IF 1.9 3区 医学 Q3 UROLOGY & NEPHROLOGY Neurourology and Urodynamics Pub Date : 2025-04-01 Epub Date: 2025-02-10 DOI:10.1002/nau.70012
Gunal Ozgur, Cagri Akin Sekerci, Yiloren Tanidir, Tufan Tarcan, Selcuk Yucel
{"title":"Predictive Factors for Complete Response to Desmopressin Treatment in Children With Primary Monosymptomatic Nocturnal Enuresis.","authors":"Gunal Ozgur, Cagri Akin Sekerci, Yiloren Tanidir, Tufan Tarcan, Selcuk Yucel","doi":"10.1002/nau.70012","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Primary monosymptomatic nocturnal enuresis (MNE) is a common problem in pediatric urology and desmopressin is the first-line medical treatment. We aimed to evaluate the predictive factors of complete response to desmopressin and the effect of desmopressin on urinary electrolyte levels in children with primary MNE.</p><p><strong>Methods: </strong>Children with MNE who were started on sublingual 120 mcg of desmopressin treatment included in the study. Children were evaluated by physical examination, urinalysis, voiding dysfunction symptom score, voiding diary and uroflowmetrics with postvoid residuals. 24-h urine was collected for density and electrolyte measurements before and at the first and third months of treatment. The children were divided into two groups according to wetting episodes at the third month, as those with complete response to the treatment (group 1) and the others (resistant or partial-response) (group 2).</p><p><strong>Results: </strong>Thirty-four children (24 boys, 10 girls) were included in the study. Median age was 8 (5-15) years. There was no difference between the urinary density, sodium, potassium, and calcium values before and during treatment (first and third months) (p = 0.737, 0.549, 0.166, 0.386 respectively). The number of wet nights in a month and the number of wetting at a night were found as the predictive factors for complete response to desmopressin (p = 0.027, p = 0.003, respectively). The number of 17 wet nights per month was calculated as the optimized cut-off point for predicting desmopressin treatment failure (p = 0.027, sensitivity = 92.3%, specificity = 47.6%, AUC [95%]: 0.729 [0.552-0.906]). Age, gender, family history, maximum voided volume in voiding diary (MVV)/expected bladder capacity (EBC) ratio, maximum bladder capacity (MBC)/EBC ratio and pretreatment urinary density, sodium, potassium, calcium levels could not predict complete response (p = 0.292, 0.051, 0.533, 0.552, 0.101, 0.570, 0.326, 0.735, 0.246 respectively).</p><p><strong>Conclusions: </strong>Desmopressin treatment had no effect on urine density and urinary sodium, potassium, calcium electrolytes similar to the literature. Urine density and electrolyte levels are not helpful in predicting desmopressin treatment response in enuretic children. Low frequency of wet nights (< 17) in a month and single bedwetting at a night are the significant factors to predict complete response to desmopressin treatment in children with primary MNE.</p><p><strong>Clinical trial registration: </strong>The study does not have a clinical trial registration number, because the study was not a randomized controlled trial and the data in the study were collected retrospectively.</p>","PeriodicalId":19200,"journal":{"name":"Neurourology and Urodynamics","volume":" ","pages":"878-884"},"PeriodicalIF":1.9000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurourology and Urodynamics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/nau.70012","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/10 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: Primary monosymptomatic nocturnal enuresis (MNE) is a common problem in pediatric urology and desmopressin is the first-line medical treatment. We aimed to evaluate the predictive factors of complete response to desmopressin and the effect of desmopressin on urinary electrolyte levels in children with primary MNE.

Methods: Children with MNE who were started on sublingual 120 mcg of desmopressin treatment included in the study. Children were evaluated by physical examination, urinalysis, voiding dysfunction symptom score, voiding diary and uroflowmetrics with postvoid residuals. 24-h urine was collected for density and electrolyte measurements before and at the first and third months of treatment. The children were divided into two groups according to wetting episodes at the third month, as those with complete response to the treatment (group 1) and the others (resistant or partial-response) (group 2).

Results: Thirty-four children (24 boys, 10 girls) were included in the study. Median age was 8 (5-15) years. There was no difference between the urinary density, sodium, potassium, and calcium values before and during treatment (first and third months) (p = 0.737, 0.549, 0.166, 0.386 respectively). The number of wet nights in a month and the number of wetting at a night were found as the predictive factors for complete response to desmopressin (p = 0.027, p = 0.003, respectively). The number of 17 wet nights per month was calculated as the optimized cut-off point for predicting desmopressin treatment failure (p = 0.027, sensitivity = 92.3%, specificity = 47.6%, AUC [95%]: 0.729 [0.552-0.906]). Age, gender, family history, maximum voided volume in voiding diary (MVV)/expected bladder capacity (EBC) ratio, maximum bladder capacity (MBC)/EBC ratio and pretreatment urinary density, sodium, potassium, calcium levels could not predict complete response (p = 0.292, 0.051, 0.533, 0.552, 0.101, 0.570, 0.326, 0.735, 0.246 respectively).

Conclusions: Desmopressin treatment had no effect on urine density and urinary sodium, potassium, calcium electrolytes similar to the literature. Urine density and electrolyte levels are not helpful in predicting desmopressin treatment response in enuretic children. Low frequency of wet nights (< 17) in a month and single bedwetting at a night are the significant factors to predict complete response to desmopressin treatment in children with primary MNE.

Clinical trial registration: The study does not have a clinical trial registration number, because the study was not a randomized controlled trial and the data in the study were collected retrospectively.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
原发性单症状性夜间遗尿症患儿去氨加压素治疗完全缓解的预测因素。
目的:原发性单症状性夜间遗尿(MNE)是儿科泌尿外科的常见问题,去氨加压素是一线药物治疗。我们的目的是评估去氨加压素完全缓解的预测因素以及去氨加压素对原发性MNE患儿尿电解质水平的影响。方法:接受舌下120 mcg去氨加压素治疗的MNE患儿纳入研究。通过体格检查、尿液分析、排尿功能障碍症状评分、排尿日记和尿流指标及排尿后残差对患儿进行评估。在治疗前、治疗第一个月和治疗第三个月收集24小时尿液进行密度和电解质测量。根据第3个月的湿发作情况将患儿分为两组,对治疗完全缓解的患儿(1组)和其他抵抗或部分缓解的患儿(2组)。结果:34名患儿(24名男孩,10名女孩)纳入研究。中位年龄为8(5-15)岁。治疗前、治疗中(1、3个月)尿密度、钠、钾、钙值差异无统计学意义(p值分别为0.737、0.549、0.166、0.386)。单月湿夜数和单月湿夜数是去氨加压素完全缓解的预测因子(p = 0.027, p = 0.003)。计算每月17个湿夜作为预测去氨加压素治疗失败的最佳截断点(p = 0.027,敏感性= 92.3%,特异性= 47.6%,AUC[95%]: 0.729[0.552-0.906])。年龄、性别、家族史、排尿日记最大排尿量(MVV)/预期膀胱容量(EBC)比、最大膀胱容量(MBC)/预期膀胱容量(EBC)比、预处理尿密度、钠、钾、钙水平均不能预测完全缓解(p值分别为0.292、0.051、0.533、0.552、0.101、0.570、0.326、0.735、0.246)。结论:去氨加压素治疗对尿密度及尿钠、钾、钙电解质无影响,与文献相似。尿密度和电解质水平对预测去氨加压素治疗对尿毒症患儿的疗效没有帮助。湿夜发生率低(临床试验注册:本研究没有临床试验注册号,因为本研究不是随机对照试验,研究数据是回顾性收集的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Neurourology and Urodynamics
Neurourology and Urodynamics 医学-泌尿学与肾脏学
CiteScore
4.30
自引率
10.00%
发文量
231
审稿时长
4-8 weeks
期刊介绍: Neurourology and Urodynamics welcomes original scientific contributions from all parts of the world on topics related to urinary tract function, urinary and fecal continence and pelvic floor function.
期刊最新文献
Assessment of the Therapeutic Efficacy of Acupuncture in Treating Postpartum Urinary Retention: A Comprehensive Approach Integrating Systematic Review and Association Rule Analysis. Utility of Pelvic Floor Therapy and Behavioral Interventions in the Neurogenic Lower Urinary Tract Dysfunction (NLUTD) Population. Surgical Outcomes of Transurethral Bladder Neck Incision and Resection in Female Primary Bladder Neck Obstruction: A Systematic Review. Intravesical Gentamicin for Prevention of Recurrent Urinary Tract Infections in Patients With Neurogenic Lower Urinary Tract Dysfunction Performing Intermittent Catheterization: A Systematic Review. Experiences and Quality of Life Impacts Related to Urinary Tract Infections in Veterans With Neurogenic Bladder: A Mixed Methods Study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1